These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1617895)

  • 21. Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.
    Lau CS; McLaren M; Hanslip J; Kerr M; Belch JJ
    Ann Rheum Dis; 1993 Sep; 52(9):643-9. PubMed ID: 8239758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian variations in clinical symptoms and concentrations of inflammatory cytokines, melatonin, and cortisol in polymyalgia rheumatica before and during prednisolone treatment: a controlled, observational, clinical experimental study.
    Galbo H; Kall L
    Arthritis Res Ther; 2016 Jul; 18(1):174. PubMed ID: 27455959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator.
    Schved JF; Gris JC; Arnaud A; Martinez P; Sanchez N; Wautier JL; Sarlat C
    J Lab Clin Med; 1992 Sep; 120(3):411-9. PubMed ID: 1517688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.
    Salvarani C; Boiardi L; Macchioni P; Rossi F; Tartoni P; Casadei Maldini M; Mancini R; Beltrandi E; Portioli I
    Ann Rheum Dis; 1995 Aug; 54(8):640-4. PubMed ID: 7677440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
    Cutolo M; Straub RH; Foppiani L; Prete C; Pulsatelli L; Sulli A; Boiardi L; Macchioni P; Giusti M; Pizzorni C; Seriolo B; Salvarani C
    J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of fibronectin in polymyalgia rheumatica giant cell arteritis.
    Puccetti L; Marotta G; Remorini E; Lucchetti A; Zuccotti M; Petrini G; Baicchi U; Ciompi ML
    Rheumatol Int; 1987; 7(6):249-54. PubMed ID: 3125593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of tissue-type plasminogen activator, plasminogen activator inhibitor and von Willebrand factor in the supernatant of endothelial cell cultures in response to the seeding of adenocarcinoma cell line HRT-18.
    Morganti M; Mittermayer C; Henze U; Carpi A; Sagripanti A
    Biomed Pharmacother; 1996; 50(8):373-5. PubMed ID: 8952858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
    Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
    Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum amyloid A as a potent therapeutic marker in a refractory patient with polymyalgia rheumatica.
    Shimojima Y; Matsuda M; Gono T; Ishii W; Ikeda S
    Intern Med; 2005 Sep; 44(9):1009-12. PubMed ID: 16258224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis.
    Pountain GD; Calvin J; Hazleman BL
    Br J Rheumatol; 1994 Jun; 33(6):550-4. PubMed ID: 8205403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiling in patients with polymyalgia rheumatica before and after symptom-abolishing glucocorticoid treatment.
    Kreiner FF; Borup R; Nielsen FC; Schjerling P; Galbo H
    BMC Musculoskelet Disord; 2017 Aug; 18(1):341. PubMed ID: 28784116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte sedimentation rate (ESR) at presentation is a prognostic indicator for duration of treatment in polymyalgia rheumatica (PMR).
    Pountain G; Hazleman B
    Br J Rheumatol; 1997 Apr; 36(4):508-9. PubMed ID: 9159557
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum soluble CD4 and CD8 levels in polymyalgia rheumatica.
    Salvarani C; Boiardi L; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Portioli I
    J Rheumatol; 1994 Oct; 21(10):1865-9. PubMed ID: 7837152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction.
    Jansson JH; Nilsson TK; Johnson O
    Heart; 1998 Oct; 80(4):334-7. PubMed ID: 9875107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study.
    Mallya RK; Hind CR; Berry H; Pepys MB
    Arthritis Rheum; 1985 Apr; 28(4):383-7. PubMed ID: 2859021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
    Mossard JM; Wiesel ML; Cazenave JP; Grunebaum L; Drawin T; Kieny JR; Roul G; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1813-8. PubMed ID: 2514633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aortic endothelial cell von Willebrand factor content, and circulating plasminogen activator inhibitor-1 are increased, but expression of endothelial leukocyte adhesion molecules is unchanged in insulin-dependent diabetic BB rats.
    Ribau JC; Samis JA; Senis YA; Maurice DH; Giles AR; DeReske M; Absher PM; Hatton MW; Richardson M
    Atherosclerosis; 2000 Apr; 149(2):331-42. PubMed ID: 10729383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed onset of polymyalgia in polymyalgia rheumatica.
    Greenstone M; Shaw AB
    Br J Rheumatol; 1986 Feb; 25(1):82-4. PubMed ID: 3942849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma coagulation profiles in patients with severe primary pulmonary hypertension.
    Hoeper MM; Sosada M; Fabel H
    Eur Respir J; 1998 Dec; 12(6):1446-9. PubMed ID: 9877507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.